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• Given due regard to the need to eliminate discrimination, harassment and victimisation, to 
advance equality of opportunity, and to foster good relations between people who share a relevant 
protected characteristic (as cited under the Equality Act 2010) and those who do not share it;  
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NHS England and this report 
As stated above promoting equality and addressing health inequalities are at the heart of NHS 
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The information in this report  was compiled using a whole population approach to sampling, and 
therefore included all groups, and did not exclude any potentially vulnerable or disadvantaged 
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Analysis of the resulting data found that the proportion of those who responded to the survey from 
a ‘non-white’ background were markedly lower than those from a ‘white’ background. This is a 
concern and something we will look to address in future research programmes of this kind ; as part 
of this process we will conduct further analysis of the colorectal cancer survivor data to understand 
if there are factors that might have contributed to this. 
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Foreword 
 
The publication of this report represents an important milestone in the evaluation of quality of life 
for people living with and beyond colorectal cancer in England as it is the first national whole 
population cancer survey using Patient Reported Outcome Measures (PROMs).  
Current estimates indicate 240,000 people in the UK are living with or beyond a diagnosis of 
colorectal cancer, and this number is expected to double to 630,000 by 2040. Whilst an increase in 
survival rates is clearly a great accomplishment, there are unintended negative consequences 
associated with this. As a result of having colorectal cancer, and undergoing the associated 
treatments such as radiotherapy, chemotherapy and surgery, the quality of life of those affected by 
it can potentially be significantly reduced.   
There were 21,802 individual responses to the survey which was carried out in 2013 and sent to 
people diagnosed with colorectal cancer during 2010 and 2011 who survived between 12 and 36 
months post-diagnosis. 
Respondents described different parts of their journey from a diagnosis of colorectal cancer to 
treatment and through to their experiences of aftercare. Respondents often related challenges 
they experienced to their quality of life to a greater or lesser extent. These 'frequently occurring 
challenges' include:  The emotional impact of cancer and treatment; On-going social and financial 
problems that made life difficult;  Long-term and age-related illnesses that could exacerbate, or be 
exacerbated by, problems associated with cancer treatment; Unpleasant physical side-effects of 
treatment. 
The information in this report will be of vital importance to: 
 describe the quality of survival of people with colorectal cancer 
 identify consequences of survival and impact on function  
 identify factors that impact on outcome, including treatment  
 compare outcomes by service provider organisations 
 support enhanced commissioning & delivery of care 
 enable provision of appropriate health & social care  
 use in clinical trials & supportive care research 
This report also provides an exciting opportunity to share information to support development and 
commissioning of robust living with and beyond cancer services across the health economy. 
I hope this report challenges health and social care commissioners and providers to address the 
issues identified in this survey. 
 
Mr Sean Duffy 
National Clinical Director for Cancer: NHS England 
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Executive summary 
Methodology 
 Individuals alive 12-36 months after a diagnosis of colorectal cancer were identified via the 
National Cancer Registration Service and were sent a questionnaire in January 2013. 
 Of 34,467 individuals approached, 21,802 returned a fully or partially completed questionnaire 
(63% response rate). The data presented here is based on the responses to those 
questionnaires. 
Demographics 
 62% of respondents had colon cancer, 7% had recto-sigmoid cancer and had 31% rectal cancer.  
55-64 and 65-74 year olds were most likely to respond.  White people and those living in the 
least deprived areas were more likely to respond.   
 20% reported no other long term condition (LTC), 30% had one other, 20% two others and 23% 
three or more other LTCs. 
Health status measured with EQ-5D 
 35% of all colorectal respondents reported no problems on the EQ-5D (no issues identified 
across the 5 domains of EQ-5D – pain/discomfort, self-care, usual activities, mobility, 
anxiety/depression).  Those with colon cancer were more likely to report this ‘perfect’ health 
state (37%) compared to those with rectosigmoid cancer (36%) and rectal cancer (29%).  Males 
with colorectal cancer were more likely to report ‘perfect’ health than females, with the 
difference being most marked for those with colon cancer.  
 65-74 year olds were the most likely to report ‘perfect’ health, with those aged over 85 years 
and under 55 years least likely to report this health state. Those with concurrent LTCs, those 
with recurrent or residual disease and those with a stoma were much less likely to report 
‘perfect’ health. 
 EQ-5D data could be age- and sex- matched against the general population using the Health 
Survey for England 2011 (HSE 2011) for 4,615 individuals.  31% of the colorectal survey 
respondents reported being in ‘perfect’ health, whilst 40% of HSE 2011 respondents were in this 
health state.  The largest discrepancy was reported by the colorectal cohort aged under  55 
years (27% colorectal cohort and 50% HSE 2011) with the next largest discrepancy being for 
those aged 55-64 years with colorectal cancer (34% vs 40%). Those aged 65 years and over with 
colorectal cancer reported similar levels of ‘perfect’ health compared to the general population.  
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 Mobility and usual activities were the EQ-5D domains most likely to have been affected in 
individuals following a colorectal cancer diagnosis (compared to the general population). 
Stoma 
 12-36 months from a diagnosis of colorectal cancer, 21% of individuals reported the presence of 
a stoma (10% colon, 20% rectosigmoid, 43% rectum).  20% of those with a stoma were 
embarrassed quite a bit or very embarrassed  - individuals with rectal cancer living with a stoma 
were less embarrassed by it.  They equally had less difficulty caring for it ( 9% rectum, 15% 
rectosigmoid, 13% colon).   
  The presence of a stoma significantly reduced the proportion of individuals reporting ‘perfect’ 
health (19%) on the EQ-5D, whilst those who reported a reversal of stoma had almost the same 
level of ‘perfect’ health (35%) as those known to have never had a stoma (40%).  The presence 
of a stoma was associated with the reporting of higher levels of social distress on the Social 
distress Inventory (SDI), whilst those who reported having had a stoma reversed showed little 
difference with those who had never had a stoma. 
Bowel, urine and sexual issues 
 22% of those without a stoma reported they had little or no control of their bowels. 7% 
reported a significant issue with diarrhoea. 
 20% reported having little or no appetite and 20% reported being unable to digest food well. 
 No difficulties with urinating were reported by the majority: Overall 4% reported difficulty 
urinating with 13% reporting urinating more frequently than normal and 5% reporting leaking 
urine.  These problems were slightly more common in the rectal group. 
 25% of respondents reported difficulties with sexual matters with those diagnosed with rectal 
tumours being most affected (rectal tumours 38%, rectosigmoid 24%, colonic tumours 18%). 
 40% of respondents were unhappy with their appearance whilst 35% were happy. 
Social functioning 
 15% respondents reported significant social distress (18% rectal, 15% rectosigmoid, 14% colon).  
Issues with ‘everyday living’ (19%) and ‘self and others’ (18%) were more common than ‘money 
matters’ (16%).  Social distress was most marked for the under 55 years and 85+years age 
groups, no gender effect was identified.  
 Deprivation was linked to the levels of social distress experienced 12-36 months after a 
diagnosis of colorectal cancer, with increasing deprivation being associated with a greater 
incidence of reported social distress.   
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 High social distress scores were more likely in those reporting either recurrent (35%) or residual 
but treated disease (35%) as opposed to those reporting to be in remission (11%).  The presence 
of increasing numbers of additional LTCs was linked to increasing numbers reporting high levels 
of social distress.   
 Difficulties with travel plans were reported by 22% of respondents, again this was most marked 
following a diagnosis of a rectal tumour (rectum 26%, rectosigmoid 21%, colon 19%). 
 40% experienced trouble sleeping and 40% reported feeling tired.  30% reported memory loss 
whilst 29% experienced mood swings, 29% reported irritability and 28% had difficulty 
concentrating. 
Fear of cancer spreading, recurring or death 
 Over half the respondents (56%) had fears of their cancer returning, 46% had fears of their 
cancer spreading and 30% experienced fears about death and dying.   
Health and social care support 
 Over three quarters of people reported being supported well all the time by their hospital with a 
further 14% some of the time. 6% reported not needing support whilst 2% felt never supported. 
 55% reported being supported by their GP at all times with a further 14% some of the time.  9% 
felt they never needed support whilst 14% reported never receiving support. 
 Health and Social Service support was reported to be appropriate by 36% with a further 18% 
reporting support to a certain extent.  10% reported not receiving appropriate support whilst 
36% felt they did not need help. 
Lifestyle 
 35% of respondents reported doing 30 minutes of exercise on no days each week, 44% did 
between 1 and 4 days each week,  21% did the recommended 5 or more days each week. 
 Around 6% of respondents described themselves as smokers, nearly 40% as ex-smokers and 
over 50% as non-smokers. A slightly higher proportion of people with rectal tumours self-
reported as smokers or ex-smokers. Of those respondents who had rectal tumours and classed 
themselves as ex-smokers, a slightly higher proportion quit 1-2 years ago and a slightly lower 
proportion quit more than 5 years ago compared with tumours of the colon and rectosigmoid 
tumours.  
Respondents’ comments 
 An open-ended free-text question was placed at the end of the PROMS questionnaire.  A 
quarter of the survey respondents (n= 5,634, 25.8%) chose to answer to this question.  
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 The majority of comments were positive, with respondents expressing gratitude and praising 
individual healthcare professionals, departments, hospitals or the NHS as a whole. However, 
alongside these very positive comments there were also many less favourable.  
 Respondents described different parts of their journey from a diagnosis of colorectal cancer to 
treatment and through to their experiences of aftercare. Respondents often related challenges 
they experienced to their quality of life to a greater or lesser extent. These 'frequently occurring 
challenges' include:  The emotional impact of cancer and treatment; On-going social and 
financial problems that made life difficult;  Long-term and age-related illnesses that could 
exacerbate, or be exacerbated by, problems associated with cancer treatment; Unpleasant 
physical side-effects of treatment. 
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Introduction 
Aims of the study 
 
Around 40,000 individuals are diagnosed with colorectal cancer each year in the UK1. Mortality 
from colorectal cancer has reduced as a result of both advances in medicine and technology, and 
potentially through earlier identification and treatment of colorectal cancer through better 
screening2. This has led to an increase in the number of people living in the UK that have survived 
colorectal cancer. Current estimates indicate 240,000 people are living in the UK with or beyond a 
diagnosis of colorectal cancer, and this number is expected to double to 630,000 by 20403. Whilst 
an increase in survival rates is clearly a great accomplishment, there are unintended negative 
consequences associated with this4. As a result of having colorectal cancer, and undergoing the 
associated treatments such as radiotherapy, chemotherapy and surgery, the quality of life of 
survivors can potentially be significantly reduced.   
The study aimed to explore the extent to which health-related quality of life is affected by the 
disease, and sought to identify key areas where more can be done to improve the quality of 
survival after colorectal cancer. These effects are explored through the analysis of survey questions 
answered by survivors of colorectal cancer relating to their health-related quality of life and their 
experience of care by the NHS.  
Context of the study 
 
The process of collecting patient reported outcome measures (PROMs) using questionnaires is a 
method that has recently been adopted by the NHS. PROMs data have been collected on four 
elective procedures nationally since April 20095 and are becoming increasingly important forming 
part of the NHS Outcomes Framework for Domain 3 around helping people to recover from 
episodes of ill health or following injury6. 
More specifically for colorectal cancer, the feasibility of collecting PROMs data was tested through 
a pilot study in July 20117 which confirmed the value of collecting PROMs data on four different 
cancer tumour types (breast, prostate, colorectal and non-Hodgkin’s lymphoma). The results 
highlighted a range of quality of life issues experienced by cancer survivors. 
This study was commissioned by the Department of Health as a follow-on from the pilot study. In 
January 2013 surveys were sent to people diagnosed with colorectal cancer during 2010 and 2011 
who survived between 12 and 36 months post-diagnosis. This report describes how the study was 
undertaken and presents a high level analysis and interpretation of the results. Accompanying this 
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report are two excel based tools which should be used alongside this report to provide more 
detailed information. The National Reporting Tool explores the national findings by respondent 
characteristics and tumour type and includes information on the free text comments provided. The 
NHS Trust, CCG and SCN level data toolkit enables the results from each Strategic Clinical Network 
(SCN), Clinical Commissioning Group (CCG) and Hospital NHS Trust to be visualised. This tool 
includes the responses to each question in the survey. Additionally a set of peer-reviewed journal 
articles will be produced using the survey data.  
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Methodology  
Study design  
 
The cohort of individuals to be approached was identified via the National Cancer Registration 
Service (NCRS) using the following criteria: 
- The person was over 16 years old 
- The person had survived 12-36 months since their diagnosis of colorectal cancer in 2010 or 
2011 
- The person had received treatment in the NHS in England 
Colorectal cancer was defined as those patients who had cancer of the colon, cancer of the recto-
sigmoid junction or cancer of the rectum as per the International Classification of Diseases register 
(ICD-108 codes C18-C20). We estimate that >97%of the eligible cases were identified. 
 Every effort was made to ensure that no deceased persons received the survey. The questionnaire 
was sent out to people with a covering letter outlining the study and up to 2 reminders were sent 
to those who did not respond. A phone line was provided to assist in completing the questionnaire 
should anyone have any queries. Consent to take part in the survey was through the return of a 
fully or partially completed survey. Individuals who declined to consent either did not return the 
survey or returned the questionnaire blank. 
 The questionnaire comprised of 76 questions with an additional comments box. The questions 
were divided into a number of different sections outlined below.   
 General questions  -  a range of questions asking about the type of treatment the person had, 
the length of time since their treatment, how well their cancer had responded to treatment 
and whether they had a stoma or not. 
 Outcome questions - a set of questions using three different instruments (described below) to 
assess how the patient felt about the impact of the cancer physically and emotionally. 
 Overall support and care - a number of questions about the care the person received in 
primary care (GP/community care) and secondary care (hospital), as well as questions around 
access to information and support, and more general questions about lifestyle (smoking and 
exercise). 
 About you - demographic questions were included to enable the results to be considered 
alongside factors such as age, sex, deprivation, ethnicity, and presence of long term 
conditions. 
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 Comments - a free text box was available for patient’s to make any additional comments on 
any aspects of living with cancer not touched on elsewhere in the survey or to provide further 
views and explanations. 
Questionnaire instruments 
 
The outcome questions in the survey were made up of three instruments: the EQ-5D, FACT items 
and SDI. These instruments are summarised below in brief. 
EQ-5D (Euroqol 5 level)  
This is a generic health-related quality of life measure. The instrument includes 5 different 
dimensions covering: Mobility, Self-care, Usual activities, Pain/discomfort and Anxiety/depression. 
The individual is asked to select from 5 different options to describe how they feel ranging from ‘no 
problems’ to ‘extreme’ problems (questions 5-9 in the survey). 
FACT items (Functional Assessment of Cancer Therapy)  
Questions specific to cancer were taken from a larger survey instrument to understand more about 
the physical and emotional impact on quality of life. The individual responded to a set of 
statements on a scale from ‘not at all’ (no issues) to ‘very much’ (major problems) (questions 10-22 
in the survey). 
SDI (Social Difficulties Inventory)  
This instrument is designed to look at the impact of cancer on issues such as family life, social 
activities, finances and work. The respondent is asked to rate their level of difficulty on a number of 
questions ranging from ‘no difficulty’ to ‘very much’ (questions 26-46 in the survey). 
Additional questions were also included in the survey asking the person to assess the extent to 
which they agree with a set of statements around moods and feelings, and questions related to the 
respondents’ views on their healthcare experience and lifestyle. These were used to capture any 
additional important health related quality of life issues not covered by the instruments. 
Handling quantitative data 
 
This section looks at how the quantitative data was handled prior to analysis. As the eligible 
participants were identified via the NCRS, additional cancer registration data were available. 
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Therefore, some of the information is taken from the questionnaire responses and some from the 
cancer registry. 
Age, sex and Duke’s stage of disease at diagnosis were taken from the cancer registry data. Age was 
categorised as <55, 55-64, 65-74, 75-84, and ≥85 years. Deprivation quintiles were derived, based 
on the 2010 index of multiple deprivation (IMD9), using postcode of residence at the time the 
individual completed the survey.   
Self-reported ethnicity was grouped into white and non-white; this could not be broken down 
further due to the small numbers of respondents from minority ethnic groups. Participants were 
asked if they had any long term conditions (LTC) other than their cancer diagnosis and were asked 
to tick the appropriate LTCs within a given list (question 72 of the Colorectal PROMS survey). This 
variable was categorised into ‘no other LTC’, ‘one other LTC’, ‘two other LTCs’, and ‘three or more 
LTCs’.  Information on disease status (remission, treated but still present, no treatment, recurrence, 
not certain), treatments (surgery, radiotherapy and chemotherapy) and stoma status (present, 
reversed, no stoma) were derived from self-reports captured by the questionnaire.   
EQ-5D 
The 5-level version of EQ-5D10 records the respondents’ self-assessed problems on each of five 
domains.  These data may be summarised as a single index score using a standard algorithm; scores 
range from -0.5 to 1, where 1 is the maximum score for an individual reporting no problems on any 
of the domains.  Due to the highly skewed distribution of the scores (median=0.84, IQR=0.71-1.0), 
this outcome variable was categorised as ‘perfect’ (a score of 1) or ‘less than perfect’ health (a 
score <1).  It should be noted that ‘perfect’ health here is defined exclusively in terms of the 
dimensions specified by the EQ-5D descriptive classification and that it remains possible for 
patients to experience health problems on otherwise non-defined/unobserved dimensions 
FACT items and other condition specific 
Bowel cancer specific questions from FACT items11 were examined separately (the FACT total score 
could not be calculated as only the certain relevant questions were included). The five possible 
responses were grouped into three categories for ease of presentation: Not at all/A little, 
Somewhat, Quite a bit/Very much. The analysis of questions relating to bowel function was limited 
those without a stoma, as it was felt that individuals with a stoma present could interpret the 
questions in a variety of different ways. 
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SDI 
The Social Difficulties Inventory12 (SDI) contains 21 questions, 16 of which form the main outcome 
measure (SD-16). The SD-16 scores were examined, along with the scores on the three subscales 
that form the SD-16: ‘Everyday living’, ‘Money matters’ and ‘Self and other’. Higher scores on the 
SD-16 and subscales indicate a more negative impact on quality of life.  Scores of more than 10 on 
the SD-16 suggest that there is a significant negative effect on the individual’s ability to cope and 
intervention may be required. These individuals are classed as being in ‘social distress’. The levels of 
‘social distress’ responses were examined on a range of characteristics. The subscale scores and the 
responses to five questions that do not form part of the wider SD-16 were examined separately. 
Health Survey England 
In order to make some comparisons of the health-related quality of life (HRQL) of colorectal 
survivors with the general population, the Health Survey for England 2011 (HSE 2011)13 was used. 
This is a large household survey (8,610 individuals aged over 16) which measures HRQL using EQ-5D 
allowing direct comparison. The colorectal PROMS and HSE datasets were age and sex matched, 
creating a comparable sample of 4615 individuals with EQ-5D responses on all five domains (this 
lower number reflects the very different age profiles of the two surveys). 
Handling qualitative data 
 
The 5,634 free text comments provided by individuals at the end of the questionnaire were 
analysed to explore their content through applying text mining methods to identify comments 
relevant to specific topics of interest (e.g. positive/negative experience). Based on substantive work 
to describe the experience of living with and beyond cancer in a thematic framework14 and 
methodological work around search strategy development for systematic reviews15-16, the thematic 
framework was applied to patient comments and used to manually classify a random sample of 
comments. This manually coded sample was then used to apply supervised machine learning 
algorithms in order to automatically identify comments of specific topics of interest (e.g. 
positive/negative experience, stoma). These were then analysed to develop a tentative model that 
explained how different elements of care described by respondents determined whether their 
experiences were either positive or negative (Figure 25 in results section).   
To analyse responses to the free-text comments box at the end of the questionnaire, text mining 
techniques were used to identify comments specific to perceptions of service quality experienced 
by respondents. Text mining combines methods from natural language processing, information 
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retrieval and machine learning to explore research questions in the social sciences17. This analysis 
consisted of three linked steps. 
 
Figure 1 – Development and Implementation of qualitative analysis 
 
1. Application of the thematic framework of the experience of living with and beyond cancer18-
19. Agreement of raters (AR, KH, RW) for the main categories of interest (Cohen’s Kappa) 
ranged from substantial (0.64) to excellent (0.87). 
2. Training and testing a set of machine learning algorithms (MLA) in order to be able to 
identify comments including certain codes (e.g. positive experience) in the remaining data 
set. 
3. Application of trained MLA’s to the remaining yet unclassified comments (n=4,834) retrieving 
2,076 comments related to positive or negative experience of care. A detailed manual coding 
was then conducted on these comments.  
 
  
Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures  
 
8 
 
Data limitations 
The information presented in this report and the associated toolkits must be interpreted with 
consideration of the issues highlighted below.  Ideally, we would have liked to present variation in 
health outcomes by service provider comparisons, however, due to these issues we did not feel 
that such comparisons would be robust or meaningful. 
1) Case ascertainment 
The survey captured data on those who survived between one and three years from the diagnosis 
of colorectal cancer.  But, survival rates are known to vary significantly across the country.  Those 
who die rapidly are likely to have more advanced disease and more co-morbidities than those who 
survive and, as demonstrated by this survey these individuals are more likely to report lower 
health-related quality of life (HRQL).  The incomplete case ascertainment of the survey prevents, 
therefore, organisational comparisons. 
2) Respondent bias 
There are significant differences in the characteristics of those who did and did not respond to the 
survey.  The elderly, those living in more socio-economically deprived areas and those with more 
advanced disease were less likely to respond.  Evidence suggests these individuals have lower 
HRQL.  Their failure to respond means their outcomes could not be included in comparative 
analyses and so makes any organisational comparisons inaccurate. 
3) Lack of control data 
No information was available from respondents on their health related quality of life prior to being 
diagnosed with their cancer.  Equally, there was no information available for non-cancer controls of 
an age, sex and socio-economic status matched population at organisational level.  The 
characteristics of populations managed by different NHS organisations are known to be 
significantly different.  Insufficient information was, therefore, available to enable assessment of 
the underlying HRQL of populations and so determine the true impact of the disease and its 
management between NHS organisations 
4) Distribution of EQ-5D scores 
The main HRQL outcome used in the survey was EQ-5D.  The results of this score display a highly 
skewed distribution.  Modelling this is methodologically difficult and requires the development of 
appropriate methods to produce robust provider comparisons.  
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Results 
Response rates and response bias 
The NCRS identified 35,213 individuals with a diagnosis of colorectal cancer in 2010 or 2011. Of 
these, 746 (2.1%) were removed as the individual had died leaving a final sample of 34,467. Of 
these, 21,802 individuals returned partially or fully completed questionnaires giving a response rate 
of 63.3%. The characteristics of responders and non-responders were compared to see whether 
certain characteristics seemed to influence the likelihood of a person completing the survey. This is 
important as response bias may influence the outcomes. Below are the key findings on response 
rates (see table 1 for details). 
1) Age - The 55-64 and 65-74 age groups had the highest response rates (both 67.7%) and the 
85+ had the lowest response rate (49.0%) 
 
2) Sex - More males than females were surveyed (56.8% versus 43.2%). The response rate was 
slightly higher for males than females (64.8% in males and 61.3% in females) 
 
3) Ethnicity - 71.9% of people approached were white, and 3.1% non-white. The response rate 
was higher for white (64.9%) compared to non-white (44.7%) 
 
4) Stage of disease - Response rates were higher for individuals diagnosed with early stage 
disease (Dukes A, 68.9%) compared to those with later stage disease (Dukes D, 59.2%) 
 
5) Deprivation - Individuals living in more deprived areas were less likely to respond (52.1% 
compared to 70.2% living in the least deprived areas 
 
The key findings from the response rates suggest that those over 85, those from a non-white ethnic 
group and people living in more deprived areas were significantly less likely to respond to the 
survey. 
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Characteristics of respondents 
 
The characteristics of the survey respondents were examined overall and split by tumour type (see 
table 2 for details). 
1) Tumour type - Individuals with colon tumours accounted for 62% of respondents, 7% were 
rectosigmoid and 31% were rectum tumours 
 
2) Age  -  Individuals with colon tumours tended to be slightly older - a lower proportion were 
under 55 years old (29% were under 55 compared to 37% for rectosigmoid and 40% for 
rectum), and a higher proportion were over 75 years old (35% for colon tumours compared 
to 27% for rectosigmoid and 25% for rectum). 
 
3) Sex   - A higher proportion of respondents were male (58% compared to 42% overall). This 
pattern was reflected across all tumour types, particularly for rectosigmoid and rectum 
where the proportion of males was much higher than females. 
 
4) Deprivation - Around 50% of respondents were from the least and second least deprived 
areas, therefore far fewer people were from the remaining deprivation quintiles, with less 
that 12% overall being from the most deprived quintile. 
 
5) Disease status - Over three-quarters of respondents for each tumour type reported that 
they were in remission, 5% said the cancer was still present and 3% said it had returned 
and 10 % did not respond. The split across tumour types was fairly even. 
 
6) Stoma status - 10% individuals with colon tumours reporting having a stoma and 7% said 
their stoma had been reversed. For rectosigmoid the proportions were 21% with a stoma 
and 23% reversed, and for rectum tumours 42% said they had a stoma and 31% said their 
stoma had been reversed. 
 
7) Treatment type - 51% of colon patients reported having surgery only, with another 39% 
reporting that they had surgery combined with chemotherapy and/or radiotherapy 
treatment. For rectum patients 30% had surgery only, and 59% had surgery with 
chemotherapy and/or radiotherapy. 
 
8) Long term conditions - The split by number of long term conditions was consistent across 
all three tumour sites, with around 20% of people reporting that they had no other long 
term conditions, nearly one third reporting that they had one other long term condition, 
and around 40% stating they had 2 or more long term conditions.  
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Generic PROMs - EQ-5D 
 
The concept of ‘perfect’ health using the EQ-5D was explored by tumour type and patient 
characteristic. The EQ-5D was analysed in this way due to the skewed distribution of the utility 
scores. ‘perfect’ health overall for the EQ-5D was defined as a response of ‘no problem’ on any of 
the five domains. 
Figure 2 - Distribution of EQ-5D utility scores 
 
Combining the three tumour types, over one third (35%) of all colorectal respondents reported 
‘perfect’ health (no problems on any of the EQ-5D domains). Looking at the separate tumour types, 
colon and rectosigmoid cancer patients were more likely to report ‘perfect’ health (37% and 36% 
respectively) compared with rectal cancer respondents (29%).  
There were slight differences between tumour types in relation to age, sex, deprivation and 
treatment, but the largest effects were seen in relation to disease status and number of long term 
conditions. The scores for all tumour types for ‘perfect’ health are presented below by each 
characteristic. For the breakdown of ‘perfect’ health by tumour type for each characteristic see the 
national tool. 
 
 
 
Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures  
 
12 
 
Figure 3 - Proportion of respondents in ‘perfect’ health by age group 
 
Figure 4 - Proportion of respondents in ‘perfect’ health by gender 
 
Figure 5 - Proportion of respondents in ‘perfect’ health by deprivation quintile 
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Figure 6 - Proportion of respondents in ‘perfect’ health by disease status 
 
Figure 7 - Proportion of respondents in ‘perfect’ health by number of long term conditions 
 
 
Across the five EQ-5D domains, the highest proportion of respondents reported no problems with the 
‘self-care’ domain (84.6%) (figure 8). The domain with the lowest proportion of respondents reporting 
no problems was for pain and discomfort with 51.9% of respondents reporting ‘no problems’ on this 
domain. 
By tumour type, respondents with rectal tumours had slightly worse outcomes on the EQ-5D domains 
compared with other tumour types on the ‘usual activities’ and ‘pain/discomfort’ domains. 
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Figure 8- Proportion of respondents reporting no problems by EQ-5D domain 
 
Comparison with Health Survey for England 2011 
 
The outcomes for 4,615 colorectal cancer survivors were compared with an age and sex matched 
sample of people from the Health Survey for England (HSE) 2011. As the EQ-5D measure was used in 
both the PROMs survey and the HSE 2011, levels of ‘perfect health’ could be compared. Levels of 
‘perfect’ health were found to be lower in colorectal cancer survivors compared to the general 
population (31.2% versus 40.1%). This difference was largest in the under 55 age group, where only 
27% of colorectal cancer survivors (compared 50% of the general population) reported ‘perfect’ 
health.  
 
Figure 9 - Comparison of ‘perfect’ health by age group for colorectal cancer survivors and HSE 
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The proportion of people in ‘perfect’ health was also compared across the 2 groups by each of the EQ-
5D domains. Apart from the pain/discomfort domain which was similar across both groups, lower 
proportions of colorectal cancer survivors reported that they were in ‘perfect’ health on each of the 
other four domains. The difference was particularly significant for usual activities (57% v 73%) and 
anxiety/depression (57% v 72%). 
 
Figure 10- Comparison of ‘perfect’ health by EQ-5D dimension for colorectal cancer survivors and HSE 
 
 
Ideally, levels of ‘perfect’ health in colorectal cancer survivors and the general population would have 
been compared according to the number of long term conditions reported, but this was not possible 
due to different list of conditions used in the colorectal PROMs and HSE 2011 surveys. Only those 
without any reported long-term conditions could be compared. ‘Perfect’ health was reported by 41% 
of colorectal cancer survivors and 60% of HSE 2011 respondents with no other long-term conditions. 
Social Difficulties  
 
The Social Difficulties inventory was used to assess a number of problems that cancer survivors may 
experience related to aspects of life around family, social activities, finances and work. Overall 15% of 
colorectal cancer survivors were classed as being in ‘social distress’ (a score of 10 or more on the SD-
16).  Across the tumour types, a higher proportion of rectal cancer survivors were in ‘social distress’ 
(18%, compared to 14% for colon and 15% for rectosigmoid).  
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Figure 11- Proportion in ‘social distress’ on the SD-16 by tumour type 
 
On the three subscales, those with rectal tumours had a higher proportion of people reporting 
negative outcomes. The largest difference was seen for the money matters subscale where 14% of 
colon cancer survivors reported a high score, compared with 19% of rectal cancer survivors (see 
national tool for details). 
 
Figure 12 - Proportion reporting a score of 2 or more on the ‘money matters’ subscale 
 
 
The SD-16 score for ‘social distress’ was examined by tumour type and patient characteristic.  For sex 
there was no difference between males and females in ‘social distress.’  By age, the youngest age 
group (<55 years) and the oldest age group (85+) had the highest proportion of people in ‘social 
distress’. Colorectal survivors from more deprived backgrounds tended to report more ‘social distress.’ 
Those in remission had the lowest levels of ‘social distress.’ Presence of a stoma and having more long 
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term conditions were all associated with increased levels of ‘social distress.’ Levels of ‘social distress’ 
also varied by treatment type, those undergoing surgery alone reported the lowest ‘social distress.’ 
There were no major differences between tumour types. Survivors of rectosigmoid tumours differed 
on some characteristics, but the numbers from which the proportions are calculated are small. See the 
national tool for the tumour site breakdown by characteristic. 
 
Figure 13 - Proportion of respondents in ‘social distress’ by age 
 
 
Figure 14 - Proportion of respondents in ‘social distress’ by sex 
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Figure 15 - Proportion of respondents in ‘social distress’ by deprivation quintile 
 
Figure 16 - Proportion of respondents in ‘social distress’ by disease status 
 
Figure 17 - Proportion of respondents in ‘social distress’ by number of long term conditions 
 
Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures  
 
19 
 
Figure 18- Proportion of respondents in ‘social distress’ by treatment type 
 
Figure 19- Proportion of respondents in ‘social distress’ by stoma status 
 
 
In addition to the 16 SDI questions that make up the SD-16 score and subscales, there are five other 
questions which measure ‘social distress.’ These include questions around plans to have a family, 
sexual difficulties, concerns with where you live, travel plans and other areas of everyday life. Travel 
plans and sexual difficulties were the only areas where there was more evidence of social distress with 
25% of respondents reporting ‘quite a bit/very much’ for difficulties around sexual matters and 22% 
reporting problems with travel. The difference across tumour types was also greatest for these two 
questions, with individuals with rectal tumours reporting more problems. Sexual difficulties will be 
explored in more detail in the next section.  
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Condition- specific PROMs 
 
The data was analysed to look at specific cancer-related outcomes. All of the condition-specific 
questions are presented by tumour type in the national tool. This section of the report focuses on the 
key issues that were identified around bowel control, urinary function, body image and sexual matters 
and psychological issues. 
Bowel control 
Bowel control is a key issue that affects quality of life in individuals with colorectal cancer. Figure 19 
shows that 22% of respondents without a stoma felt they had little or no bowel control and 11% felt 
that they only had some control. This did not vary by tumour site, although the proportion answering 
‘Somewhat’ was higher in the rectal cancer group (16.5% compared to 12.3% in the rectosigmoid 
group and 8.9% in the colon group).  
Figure 20- Proportion of people without a stoma stating that they had control of their bowels 
 
Those with a reversed stoma reported similar bowel control to those that had never had a stoma 
(21.4% and 22.3% respectively reported no or little control). 943 people (6.7% of respondents without 
a stoma) reported having diarrhoea ‘Quite a bit or Very much.’ This was similar across the three 
tumour sites.  
Urinary function  
Urinary function also negatively affects quality of life in individuals with colorectal cancer. The 
proportion of respondents reporting having difficulty urinating was 3.8%. Of the colorectal survivor 
respondents, 12.7% reported that they urinated more frequently and 4.6% answered ‘Quite a bit/Very 
much’ to the questions regarding leaking urine.  
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Figure 21 - Proportion of people who had difficulty urinating 
 
When considered together, 15.4% of respondents answered ‘Quite a bit/Very much’ to any of the 
three urinary function questions. By tumour site, the figures were 14.1%, 15.1% and 17.9% for the 
colon, rectosigmoid and rectal cancer groups respectively. Urinary problems seemed to be slightly 
more of an issue for those people with rectal tumours rather than colon tumours. 
Other functional outcomes 
Key findings relating to other functional outcomes are presented below: 
Swelling or cramps in the stomach area - 89% of respondents reported that they had no, or very little 
swelling or cramps. However 6% (1,024 individuals out of 20,175 who completed this question) said 
they had quite a lot, or a lot, of swelling or cramps in the stomach area. Across the 3 tumour sites, 
patients with rectum tumours reported slightly worse outcomes around this. 
Good appetite -70% of respondents reported that they had a good appetite, however 20% (4,125 out 
of 20,497 people) reported having little or no appetite. This was similar by tumour type. 
Losing weight -96% of respondents reported that they had either not lost weight or lost very little, and 
402 individuals out of 1,9850 (2%)  said they had lost quite a bit or a lot of weight. This was consistent 
across tumour sites.  
Digesting food - 73% of respondents reported that they could digest food well, however 20% (3,998 
people out of 20,326) reported had major problems digesting food. The reported negative impact on 
quality of life is proportionally much higher than on other FACT item questions suggesting that 
digestion of food is an issue for people with bowel cancer. The split by tumour type was fairly even. 
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Body image and sexual matters  
10.1% of respondents reported having difficulties with their appearance or body image (answered 
‘quite a bit/Very much’) and this was higher in the rectal cancer group (13.9% compared to 9.8% in the 
rectosigmoid and 8.2% in the colon group). Individuals with a stoma (of which the majority have rectal 
cancer) report having more difficulties; 20.9% compared to 6.6% and 10.1% in the no stoma and 
reversed groups.  
Rectal cancer respondents were more likely to report having difficulties with sexual matters (25.1% 
answered ‘Quite a bit/Very much compared to 11.2% and 16.1% of colon and rectosigmoid 
respondents). 27.2% of individuals with a stoma reported sexual difficulties compared to 10.8% of 
those without a stoma and 30.1% of those that had radiotherapy reported difficulties compared to 
12.4% that did not have radiotherapy. A high proportion of respondents selected ‘Does not apply’ as 
their answer to the sexual difficulties question (36.9%). 
Psychological effects 
The psychological effects of colorectal cancer were examined. Respondents were asked to rate 
themselves on a set of statements. Over half of the respondents reported that they ‘agreed’ or 
‘strongly agreed’ that they had fears about their cancer coming back. 
 
Figure 22 - Proportion of people who ’agree/’strongly agreed they feared their cancer coming back 
 
Nearly half the respondents said they agreed or strongly agreed that they feared the cancer spreading 
(just below 50% for each of the tumour types). 
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Figure 23 - Proportion of people who ’agree/’strongly agreed they feared their cancer spreading 
 
 
Responses to the statements on ‘trouble sleeping’ and ‘always feeling tired’ were also quite high with 
around 40% of respondents agreeing or strongly agreeing with these statements. For responses to all 
nine statements around feelings and emotions, please see the national tool. 
The overall HRQL of colorectal cancer survivors in England has been identified as being significantly 
lower than that of the general population.  Bowel and sexual problems were commonly reported with 
rectal patients being most adversely affected.  Whilst these findings are intuitive, the scale of the 
reported survey with nearly 22,000 respondents has enabled detailed interrogation by tumour site and 
a wide range of patient characteristics and comparison with normative population data with the 
subsequent identification of groups at increased risk of suffering impaired HRQL.  
Respondents’ comments 
 
Of the 21,802 respondents who completed the closed questions of the PROMS survey, 25.8% took the 
option to provide comments. The content of these comments was analysed in order to gain more 
information about the perceptions respondents had of the quality of care they experienced.  
Categories of comments 
Comments were themed into groups summarised in Figure 24.  
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Figure 24 - Thematic framework of the experience of living with and beyond cancer derived from free-text 
responses to the PROMS survey questionnaire 
 
Theme Category 
 
Sub-category
 
 
Experience of 
cancer 
diagnosis and 
treatment 
Positive experiences of treatment  Excellent/ good general care 
Timely diagnosis  
Coordinated care  
Negative experiences of treatment  Diagnostic and treatment delays  
Poorly coordinated treatment  
Lack of emotional support  
Appointment cancellations  
Poor explanations / patient communication  
Poor in-patient care  
Experiences of 
living beyond 
cancer  
 
  
Lack of preparation by services 
 
Lack of information on treatment side-effects  
Lack of information concerning possible psychological impact 
of cancer and treatments  
Lack of information on self-management strategies  
Positive experience of aftercare  
Negative experiences of aftercare  Lack of aftercare/ poor admin   
Poor patient communication  
Lack of GP involvement  
Living with stoma   
Living with co-morbidities    
On-going Physical problems  Bowels  
Urinary problems  
Cognitive problems/memory loss  
Pain  
Impotence/ sex difficulties  
Fatigue  
Peripheral neuropathy  
Other physical problems  
Caring responsibilities 
On-going social and financial 
problems  
Financial worries/ benefit problems  
Impact of cancer on friends/relatives 
Lack of social services support 
Fear of recurrence  
On-going emotional /psychological 
problems  
Genetic concerns for relatives  
Poor body image  
Depression/ feeling isolated  
Anxiety 
Other psychological problems 
Keeping active  
Coping/ self-management 
strategies  
Returning to employment  
Use complementary therapies (NPIs)  
Acceptance/ live life for today  
Support from friends/families  
Maintain ‘positive’ approach  
Adopting healthier lifestyles  
Other coping strategies  
No problems experienced   
Issues 
unrelated to 
the experience 
of living 
beyond cancer 
Issues related to the questionnaire 
structure  
 
Miscellaneous   
 
Description of disease and 
treatment pathway  
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The majority of comments were positive, with respondents expressing gratitude and praising 
individual healthcare professionals, departments, hospitals or the NHS as a whole.     
“The process for diagnosis was excellent - GP acted very quickly and the [consultant] similarly 
discussed my condition and put in place a corrective action plan. This was coordinated extremely 
well by the specialist colorectal nurse. She has been a constant support and has acted as my point 
of contact throughout the three years I've been treated and followed up. ...  In summary the whole 
process was faultless and should be used as an internal case study for how to get things right.”  
“After the diagnosis I received immaculate treatment on the NHS, which was excellent at all times 
from my Consultant Surgeon and Oncologist to all the staff which I met during my treatment. I 
received nothing but the best of care and kindness. I can't express enough the praise and thanks I 
owe them all for their care of me.” 
"I have received and am still receiving the best possible treatment from the surgeon oncologist 
and colorectal nurse. I have to have regular CT scans but so far they have been clear with no sign 
of any reoccurrence of the tumour. I remain very positive about my future health but I am aware 
that the return of the cancer is possible. I keep in touch with my colorectal nurse who has been 
superb. I have the highest regard for all of those people who have been involved in my treatment” 
However, alongside these very positive comments there were also many less favourable.  
 “In the early stages I feel that living with cancer would have been made easier for me had I been 
given more detailed information of what to expect i.e. after first op when a colostomy bag was 
fitted and it leaked for the first 3 months until problems were sorted and after reversal coping was 
horrendous and no information was given on what to expect when sent home from hospital.” 
“Care in the community was poor at best. GP was OK. NHS Direct did their best. It was nobody's 
job to check I was OK, which I was. If I had less home support [it] may have been a very different 
story. Aftercare in the community needs more attention and quickly”     
Collecting these comments, and analysing those that describe both positive and negative experiences 
of care, allowed the development of a deeper understanding of the elements of the services delivered 
that make a difference to the outcomes for respondents. The proportion of positive and negative 
comments are summarised in figure 25: 
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Figure 25 - Comments (n=2,076) relating to positive or negative experiences of care quality identified via 
text mining 
Category Sub-category
 
(n=) % 
Positive experiences  Excellent/ good general care 1045 50.3 
Timely diagnosis  109 5.2 
Positive aftercare 289 13.9 
Negative experiences  Diagnostic and treatment delays  36 1.7 
Poor in-patient care 45 2.1 
Poor explanations / patient communication 78 3.7 
Lack of emotional support  78 3.7 
Lack of information on treatment side-effects  160 7.7 
Lack of information concerning possible psychological 
impact of cancer and treatments  
43 2.0 
Lack of information on self-management strategies  135  6.5 
Lack of aftercare  191 9.2 
Lack of GP involvement 52 2.5 
Stoma  365 17.5 
Not relevant  242 11.6 
 
Note: Individual participants often provided free-texts comments that were divided into more than one 
category. Accordingly, total figure does not add up to 2,076 
 
Patient experience 
Respondents described different parts of their journey from a diagnosis of colorectal cancer to 
treatment and through to their experiences of aftercare. Respondents also identified several factors 
that challenged their path to recovery, and these were coded into four categories: emotional and 
psychological problems; social and financial issues; physical side-effects of cancer treatment; and 
comorbidities and age-related illnesses. The quality of services as perceived by the respondents 
depended on how effective they were in supporting management of these challenges to quality of life. 
A tentative model was developed from the data to explain how different elements of care described 
by respondents determined whether their experiences of care were positive or negative (see fig. 26). 
The green-shaded top half of the figure has been used to represent those aspects of care associated 
with individual’s positive experiences. They comprise those elements of care to which respondents 
reportedly had access that minimised or addressed the challenges faced along the treatment pathway. 
The orange lower part of the figure lists the issues related to care that had a negative impact upon 
quality of life outcomes and delayed the transition to cancer survivorship. Quality of life may become 
worse if challenges are not addressed and a cycle of deterioration may develop, in which, for example, 
unresolved psychological issues worsen as a result of continuing uncontrolled physical treatment side-
effects and/or on-going social and financial problems. 
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Figure 26 – Tentative model of factors determining the quality of patient experience 
 
 
 
Factors associated with service delivery leading to negative outcomes 
Negative outcomes were reportedly experienced when the care respondents received inadequately 
addressed the challenges to quality of life associated with a colorectal cancer diagnosis and treatment. 
Figure 27 indicates those elements of care that sometimes led to negative outcomes. These are 
illustrated by the quotes contained in the sections below. 
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Figure 27 - Factors associated with service delivery leading to negative outcomes 
 
Delayed diagnosis 
“I went to the GP for over a year highlighting my symptoms before a referral. I found many other 
patients at hospital experienced the same. Basically if you’re youngish and not losing weight you 
don’t get referred.” 
“Very poor G.P. help in diagnosis or referral before my bowel cancer was discovered at an 
advanced stage. My wife's insistence was the main reason I was sent to the consultant as an 
emergency.”  
 
Poor inpatient care 
“Poor symptom control post-surgery whilst in-patient i.e.: No antiemetic - poor pain control - no 
emotional support.” 
“Care on hospital ward poor due to lack of nurses & support staff.” 
 
 Un-co-ordinated care 
“Appalling administration of appointments. Repeat cancellations by hospital and repeatedly 
putting appointments in wrong order... i.e. scan after the appointment to look at results. The 
system for management lets down the hard work done by medical & nursing staff.” 
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“I assume that my consultant has informed the practice of my case history but whenever I have 
contacted the practice for blood test results after hospital check-up appointments I'm told they do 
not have the information. I have no idea whether my GP knows I have been treated for cancer.” 
“In cancer care many specialists are involved, e.g. surgeons oncologists etc. There is lack of 
coordination between these specialists, i.e. no one seems to be in charge so that problems like 
stoma reversal are just seemingly from the patient's point of view forgotten” 
 
Lack of patient preparation  
“I felt I was not fully prepared for the after effects of having a permanent stoma as my operation 
happened within a matter of days of being diagnosed. I am very grateful of being cured but I feel I 
should have had more information about stoma issues.” 
 “Would have appreciated having more information on what to expect being without a colon – i.e. 
1) coping with flatulence going to the toilet frequently including the night resulting in tiredness 
leading to putting on weight & feeling poorly motivated as a result. 2) Length of time of problems 
& what to expect as they eased.” 
“The general information about chronic peripheral neuropathy was extremely vague. I have since 
found out a great deal through researching the internet. I would have welcomed more precise and 
extensive information about chronic CIPN before or at the time of treatment as this would have 
prepared me for the reality.” 
 “Anxiety is the greater problem. It is not specific to anything in particular. It would have been 
good to have had someone to talk to at the outset so that I could have been made aware of the 
danger of [experiencing] it.” 
 
Lack of emotional support 
“Psychological effects of living with an irreversible stoma. These effects are underplayed during 
pre-operative discussions. Some kind of follow-up support for mental and emotional wellbeing 
would be useful.  
I did and still do feel ‘abandoned’ following surgery and treatment for colon cancer. I appreciate 
that the oncology and surgical departments are very busy but I would have liked some form of 
counselling following discharge.” 
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Lack of aftercare 
“During diagnosis my nurses would do all that is possible to make my time as well as can be. After 
treatment it seems that you are just a number and the care aspect has gone at local level.” 
“Care in the community was poor at best. GP was OK. NHS Direct did their best. It was nobody’s 
job to check I was OK, which I was. If I had less home support may have been a very different 
story. After care in the community needs more attention and quickly.” 
“Although I was allocated a CNS I do not feel there is enough support. I feel like I am being a 
nuisance if I send her an email or wasting her time. It is evident by her response that she does not 
properly read what I have typed. “ 
 “Post-operative recovery (in following weeks/months) at home not assisted by good home 
visit/GP support especially during chemotherapy.”  
 “My cancer care was very quick and good up to the diagnosis. The care afterwards has been 
haphazard with cancelled appointments and lack of information. “ 
Factors associated with service delivery leading to positive outcomes 
Positive outcomes were reportedly experienced when the care respondents received adequately 
addressed the challenges to quality of life associated with a colorectal cancer diagnosis and treatment. 
Figure 28 indicates those elements of care that sometimes led to positive outcomes, which are 
illustrated by the quotes contained in the sections below. 
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Figure 28 - Factors associated with service delivery leading to positive outcomes 
 
 
Timely diagnosis and referral 
“The rapid response between GP, hospital and consultant/surgeon from initial GP contact 
diagnosis consultation has no doubt contributed to the success of my cancer treatment.” 
 
Diagnosed via National screening programme  
“I am so thankful that I did the bowel screening test that came through the door. I had no 
symptoms at all. No one could believe it because I was so healthy. Everyone else made sure that 
they did the test when it was offered.” 
“Because of symptoms shared with my GP (but ignored) I am grateful to the NHS screening 
programme that picked up my T4 tumour thanks to the postal test sample.” 
 
Co-ordinated care 
“Because of the excellent communication received from the medical staff throughout treatment 
I have always felt very confident & happy with all my treatment.” 
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Emotional support 
“I think that the role of the colorectal nurse in providing on-going contact and reassurance is an 
absolutely vital one and is of great benefit in helping patients to understand their condition and 
what is happening to them, and thus to bolster their morale before during and after surgery and 
thereafter generally.” 
 
Patient preparation 
“I received excellent care and attention from my consultant the nurses who cared for me after 
the operation and all the nurses. What I felt was important to me was: The consultant explained 
thoroughly what was wrong and what procedures I was to have” 
“Although chemotherapy was far from pleasant the treatment I received from hospital could not 
have been better. I was kept informed and consulted at every step of my treatment.” 
“While the cancer still had the possibility of cure we were very happy that a high level of care 
was being given & everything possible was being done we felt well informed supported by our 
specialist and consultant & in good hands.” 
“I still have slight problems with bowel movements and wind but I was advised that this would 
be the case.” 
 
Good aftercare 
“The excellent follow-up by the specialist nurses and the knowledge that I am still being 
regularly monitored after two years engenders confidence.” 
“I have been impressed and reassured by the frequent follow-up; monitoring and appointments 
and the friendliness and approachability of staff.” 
“I have excellent follow-up from [hospital] and a cancer specialist nurse in my area. I have been 
able to contact either one when especially worried or concerned.” 
“The NHS has been completely magnificent across all aspects of the system. The post-surgical 
chemo therapy regime was the toughest part of the treatment and this aspect of the system 
appeared to be the most under stress of numbers (e.g. lots of delays in the bloods/doctor 
consultation) in the outpatient system. Despite these pressures the staff behaved with great 
professionalism.” 
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Summary of respondents’ comments 
From respondents' comments it is clear that the services required to ensure positive quality of life 
outcomes include both structural aspects of service delivery and access to supportive care. 
Structural aspects of care included coordinated care across primary and secondary sectors and 
hospital departments, including good communication links, and the provision of effective aftercare. 
Supportive services were indicated as necessary to prepare individuals for the difficulties that 
emerge during their treatment journey and beyond, to support them emotionally, with practical 
advice and sign-posing to financial, benefits and employment advice, including charities like 
Macmillan and other services they may need. Indeed, had these services been available to a large 
proportion of those who reported negative experiences of cancer care within this survey, then their 
quality of life might have been greatly improved. Thus, elements of good quality services identified 
by the survey should be consistently provided to all patients with colorectal cancer if their quality 
of life is to be improved include the following: 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Patients should be provided with clear explanations of their treatment options by health professionals 
 
 Patients should be aware of who is responsible for coordinating their care, and feel able to contact a 
named clinical nurse specialist about worries and concerns they have without feeling they are wasting 
their time 
 
 Patients should be made aware of the potential psychological impact of a cancer diagnosis and 
treatment, including feelings of isolation and increased fears of recurrence, and that this might occur at 
the end of active treatment 
 
 Patients should have access to some form of emotional support across the patient journey from 
diagnosis, to treatment and aftercare, including counselling services, talking therapies and sign-posting 
to survivor support groups 
 Patients should be made aware of the possible physical side-effects of treatment, especially: bowel 
problems like diarrhoea, constipation, whether or not they have a stoma formation; urinary problems 
of incontinence; mental cognition and memory loss; fatigue; and that these problems may endure for 
some months after the end of treatment 
 
 Patients should be provided with practical advice and possible coping strategies for dealing with the 
physical side-effects of treatment  
 
 Patients should have some sign-posting to services that will enable them to deal with social, financial 
and employment issues, especially organisations that can advise them of their employment rights, 
eligibility for benefits and social services  
 
 Patients should be provided with prompt reporting of scan results and delays and cancellations of 
outpatient appointments should be minimised 
 
 Patients should feel confident that their GP is aware of the treatment they have received from within 
the secondary sector, and feel able to approach their GP practice for advice   
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Discussion 
This study has demonstrated that it is feasible to collect PROMs at a national level. The results of 
the survey have highlighted groups of survivors with lower health-related quality of life, for 
example, those aged under 55 or over 85 years, those with one or more other LTCs, those with 
active or recurrent disease, those with a stoma and those living in the most deprived areas.   
The survey captured data on a number of specific functional outcomes. Nearly a quarter of 
colorectal cancer survivors (without a stoma) reported having no or little control of their bowels. 
Reversal of a stoma resulted in similar levels of reported bowel control as those who had never had 
a stoma.  A quarter of rectal cancer survivors reported sexual difficulties. Over a third of 
respondents (predominantly females and older groups) answered ‘does not apply’ which may 
mean that the true figure is higher.  Problems with digesting food and a lack of appetite were also 
commonly reported.    
Qualitative analysis of the respondents' comments showed that a high proportion of patients 
reported positive experiences of care. However, substantial numbers had negative experiences and 
these relate particularly to lack of aftercare, information on self-management and information on 
treatment side-effects. 
A number of study limitations need to be acknowledged.  Firstly, the elderly, those from ethnic 
minorities and those living in more socio-economically deprived areas were less likely to participate 
in the survey.  However, with a good response rate of 63.3% resulting in almost 22,000 returned 
surveys, this study provides some of the best evidence to date.  Secondly, due to the highly skewed 
distribution of the EQ-5D scores, a measure of ‘perfect’ health was used but it is acknowledged that 
this may not capture the individuals ‘true’ health state.  Additionally, the visual analogue scale of 
the EQ-5D was not included. Lastly, the study design did not include a control group to provide 
baseline data. Linkage with data from HSE 2011 allowed limited comparison to the general 
population, for example, the reduction in health-related quality of life was most marked in those 
aged under 65 with little difference seen in those over 65.   
The data collected in this survey serve as a baseline for future system wide improvement 
initiatives.  The results suggest areas where efforts could be best targeted to improve aftercare 
services, such as improving bowel control and sexual function (particularly in rectal cancer 
survivors) and in providing greater support for younger patients, those with multiple LTCs and with 
recurrent disease.  
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Further research 
This report looks at the health outcomes of colorectal cancer survivors according to tumour type 
and across a range of respondent characteristics. However, this is only a snapshot of the data. 
There is a wealth of information from the survey on which further analysis can be undertaken. All 
of the data collected by the survey will be available from the Health and Social Care Information 
Centre and researchers can apply to use these data in order to further the understanding of the 
consequences of cancer and its treatment. 
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Table 1 - Respondents and non-respondents to quantitative questions 
Characteristic  Non-respondent Respondent Total Response rate  
  n % n % n % 
Sex Male 6897 54.5 12683 58.2 19580 64.8 
 Female 5768 45.5 9119 41.8 14887 61.3 
Age at diagnosis <55 1605 12.7 2040 9.4 3645 56.0 
 55-64 2457 19.4 5154 23.6 7611 67.7 
 65-74 3735 29.5 7824 35.9 11559 67.7 
 75-84 3669 29.0 5633 25.8 9302 60.6 
 85+ 1199 9.5 1151 5.3 2350 49.0 
Tumour site Colon 8119 64.1 13577 62.3 21696 62.6 
 Rectosigmoid 807 6.4 1512 6.9 2319 65.2 
 Rectum 3739 29.5 6713 30.8 10452 64.2 
Year of diagnosis 2010 5968 47.1 10523 48.3 16491 63.8 
 2011 6697 52.9 11279 51.7 17976 62.7 
Ethnic group White 8702 68.7 16079 73.8 24781 64.9 
 Mixed 35 0.3 40 0.2 75 53.3 
 Asian 236 1.9 171 0.8 407 42.0 
 Black 189 1.5 143 0.7 332 43.1 
 Other 131 1.0 124 0.6 255 48.6 
 Unknown 3372 26.6 5245 24.1 8617 60.9 
Dukes' stage of disease at diagnosis A 1101 8.7 2435 11.2 3536 68.9 
 B 2561 20.2 5149 23.6 7710 66.8 
 C 2223 17.6 4482 20.6 6705 66.8 
 D 721 5.7 1045 4.8 1766 59.2 
 Unknown 6059 47.8 8691 39.9 14750 58.9 
Index of Multiple Deprivation 1 - least deprived 2328 18.4 5484 25.2 7812 70.2 
 2 2730 21.6 5360 24.6 8090 66.3 
 3 2649 20.9 4742 21.8 7391 64.2 
 4 2609 20.6 3658 16.8 6267 58.4 
 5 - most deprived 2349 18.5 2558 11.7 4907 52.1 
Total  12665 100 21802 100 34,467 63.3 
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Table 2 - Characteristics of respondents 
Characteristic Colon Rectosigmoid Rectum Overall 
 n % n % n % n % 
Age group < 55 years 1054 7.8 167 11 819 12.2 2040 9.4 
 55-64 years 2938 21.6 385 25.5 1831 27.3 5154 23.6 
 65-74 years 4869 35.9 558 36.9 2397 35.7 7824 35.9 
 75-84 years 3876 28.5 342 22.6 1,415 21.1 5,633 25.8 
 85+ years 840 6.2 60 4 251 3.7 1151 5.3 
 Total 13577 100 1,512 100 6,713 100 21802 100 
Sex Male 7346 54.1 952 63 4385 65.3 12683 58.2 
 Female 6231 45.9 560 37 2328 34.7 9119 41.8 
 Total 13577 100 1512 100 6713 100 21802 100 
Index of multiple deprivation 1 - least deprived 3501 25.8 343 22.7 1640 24.4 5484 25.2 
 2 3399 25 363 24 1598 23.8 5360 24.6 
 3 2932 21.6 326 21.6 1484 22.1 4742 21.8 
 4 2212 16.3 271 17.9 1175 17.5 3658 16.8 
 5 - most deprived 1533 11.3 209 13.8 816 12.2 2558 11.7 
 Total 13577 100 1512 100 6713 100 21802 100 
Ethnic group White 12905 95.1 1435 94.9 6418 95.6 20758 95.2 
 Non-white 299 2.2 30 2 125 1.9 454 2.1 
 Not known 373 2.7 47 3.1 170 2.5 590 2.7 
 Total 13577 100 1512 100 6713 100 21802 100 
Duke’s stage of disease at diagnosis A 1223 9 170 11.2 1042 15.5 2435 11.2 
 B 3795 28 311 20.6 1043 15.5 5149 23.6 
 C 2896 21.3 338 22.4 1248 18.6 4482 20.6 
 D 681 5 76 5 288 4.3 1045 4.8 
 Not known 4982 36.7 617 40.8 3092 46.1 8691 39.9 
 Total 13577 100 1512 100 6713 100 21802 100 
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Table 2 - Characteristics of respondents (continued) 
Characteristic Colon Rectosigmoid Rectum Overall 
 n % n % n % n % 
Disease status Remission 10442 76.9 1158 76.6 5042 75.1 16642 76.3 
 Treated but still present 551 4.1 98 6.5 422 6.3 1071 4.9 
 No treatment 154 1.1 16 1.1 34 0.5 204 0.9 
 Recurrence 365 2.7 32 2.1 175 2.6 572 2.6 
 Not certain 1207 8.9 130 8.6 724 10.8 2061 9.5 
 No response 858 6.3 78 5.2 316 4.7 1252 5.7 
 Total 13577 100 1512 100 6713 100 21802 100 
Stoma status Present 1327 9.8 312 20.6 2848 42.4 4487 20.6 
 Reversed 957 7 350 23.1 2071 30.9 3378 15.5 
 No stoma 9655 71.1 739 48.9 1427 21.3 11821 54.2 
 No response 1638 12.1 111 7.3 367 5.5 2116 9.7 
 Total 13577 100 1512 100 6713 100 21802 100 
Treatment Surgery alone 7446 54.8 650 43 1992 29.7 10088 46.3 
 Surgery + chemo 4832 35.6 523 34.6 880 13.1 6235 28.6 
 Surgery + chemo +radio 326 2.4 181 12 2437 36.3 2944 13.5 
 Surgery + radio 91 0.7 46 3 696 10.4 833 3.8 
 Other 561 4.1 77 5.1 590 8.8 1228 5.6 
 No response 321 2.4 35 2.3 118 1.8 474 2.2 
 Total 13577 100 1512 100 6713 100 21802 100 
Long term conditions None 2750 20.3 319 21.1 1582 23.6 4651 21.3 
 1 3901 28.7 484 32 2091 31.1 6476 29.7 
 2 2872 21.2 315 20.8 1336 19.9 4523 20.7 
 3 or more 3371 24.8 307 20.3 1303 19.4 4981 22.8 
 No response 683 5 87 5.8 401 6 1171 5.4 
 Total 13577 100 1512 100 6713 100 21802 100 
 
